Targeting mesothelin in ovarian cancer

Oncotarget. 2018 Nov 16;9(90):36050-36051. doi: 10.18632/oncotarget.26350.

Authors

Azam Ghafoor¹, Anish Thomas¹, Raffit Hassan¹

Affiliation

¹ Thoracic and GI Malignancies Branch, National Cancer Institute, Bethesda, MD, USA.

No abstract available

Keywords: anetumab ravtansine; antibody-drug conjugate; chemotherapy; mesothelin; ovarian cancer.

Publication types

News
Comment